Therapeutic Device Reduces Postoperative Oxygen Desaturations
|
By HospiMedica International staff writers Posted on 04 Dec 2019 |
|
Image: The Oxistimulator TENS device (Photo courtesy of MediPines)
Peripheral stimulation technology reduces postoperative hypoxemia (oxygen desaturation) in patients at-risk for obstructive sleep apnea (OSA).
The MediPines (Orange County, CA, USA) Oxistimulator is a novel peripheral transcutaneous electrical stimulus (TES) device placed on the wrist that is designed to continuously monitor patient oxygenation levels and to reduce desaturations automatically when deemed necessary. Whenever threshold oxygen saturation (SpO2) levels are lower than 93%, the Oxistimulator provides an immediate mild electrical stimulation, a therapeutic response that is just strong enough to reverse the deterioration, without harm or discomfort to the patient.
In a double-blind study conducted at the Mayo Clinic (Rochester, MN, USA), 106 post-operative patients undergoing elective surgery who were at medium to high risk for OSA were randomized to either active stimulus (53 patients) with the Oxistimulator, or to an inactive placebo device (53 patients) at the post-anesthesia care unit. The results showed that the Oxistimulator group experienced a shorter duration of SpO2 lower than 90% than the control group, with no adverse events reported. The study was published in the November 2019 issue of the Canadian Journal of Anesthesia.
“Oxistimulator represents a breakthrough in the way that it empowers clinicians to automate their clinical response; faster response means that patients spend less time in the hypoxemia danger zone,” said Steve Lee, CEO of MediPines. “This is a novel solution to a serious clinical problem, and we are fortunate to be partnering with outstanding clinical partners to prove the clinical safety and efficacy as we bring this technology to market.”
Current pre-operative screening practices have been shown to miss nearly 50% of patients with OSA, who are at-risk for serious postoperative desaturation events that can lead to complications prolonging patient hospitalization, and in some cases, even death. Currently, the burden of catching and reducing hypoxemia after surgery falls on the clinical staff, such as nurses, who manually intervene when they see a desaturation; however, this manual process has been demonstrated to be sub-optimal.
Related Links:
MediPines
Mayo Clinic
The MediPines (Orange County, CA, USA) Oxistimulator is a novel peripheral transcutaneous electrical stimulus (TES) device placed on the wrist that is designed to continuously monitor patient oxygenation levels and to reduce desaturations automatically when deemed necessary. Whenever threshold oxygen saturation (SpO2) levels are lower than 93%, the Oxistimulator provides an immediate mild electrical stimulation, a therapeutic response that is just strong enough to reverse the deterioration, without harm or discomfort to the patient.
In a double-blind study conducted at the Mayo Clinic (Rochester, MN, USA), 106 post-operative patients undergoing elective surgery who were at medium to high risk for OSA were randomized to either active stimulus (53 patients) with the Oxistimulator, or to an inactive placebo device (53 patients) at the post-anesthesia care unit. The results showed that the Oxistimulator group experienced a shorter duration of SpO2 lower than 90% than the control group, with no adverse events reported. The study was published in the November 2019 issue of the Canadian Journal of Anesthesia.
“Oxistimulator represents a breakthrough in the way that it empowers clinicians to automate their clinical response; faster response means that patients spend less time in the hypoxemia danger zone,” said Steve Lee, CEO of MediPines. “This is a novel solution to a serious clinical problem, and we are fortunate to be partnering with outstanding clinical partners to prove the clinical safety and efficacy as we bring this technology to market.”
Current pre-operative screening practices have been shown to miss nearly 50% of patients with OSA, who are at-risk for serious postoperative desaturation events that can lead to complications prolonging patient hospitalization, and in some cases, even death. Currently, the burden of catching and reducing hypoxemia after surgery falls on the clinical staff, such as nurses, who manually intervene when they see a desaturation; however, this manual process has been demonstrated to be sub-optimal.
Related Links:
MediPines
Mayo Clinic
Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Electric Bed
DIXION Intensive Care Bed
New
Absorbable Monofilament Mesh
Phasix Mesh
Latest Surgical Techniques News
- Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery
- LED-Based Imaging System Could Transform Cancer Detection in Endoscopy
- New Surgical Microscope Offers Precise 3D Imaging Using 48 Tiny Cameras
- First-Of-Its-Kind Drug Illuminates Nerve Tissue for Faster and Safer Surgery
- Neuroform Atlas Stent-Assisted Coiling Found Effective Even in Smaller Arteries
- New Surgical Technique Safely Removes Giant Nerve Tumors
- Breakthrough Polymer Significantly Improves Safety of Implantable Medical Devices
- First-Ever Technology Makes Blood Translucent During Surgery
- Tibia Nailing System with Novel Side-Specific Nails to Revolutionize Fracture Surgery
- New Imaging Probe to Transform Brain Cancer Surgery
- New Technology More Than Doubles Success Rate for Blood Clot Removal
- Surgical Ablation During CABG Improves Survival in Patients with Preexisting Atrial Fibrillation
- New Battery Technology Delivers Additional Power to Implantable Medical Devices
- New Model Reveals Optimal Positioning of Orthopedic Screws in Fractures
- Non-Invasive Tool for Removing Lung Cancer Tumors Reduces Surgical Trauma
- Advanced Imaging Endoscopes to Revolutionize Detection and Treatment of Gastrointestinal Disorders
Channels
Critical Care
view channel
AI-Enhanced Echocardiography Improves Early Detection of Amyloid Buildup in Heart
Cardiac amyloidosis is a life-threatening condition where an abnormal protein called amyloid builds up in the heart, causing it to stiffen and lose functionality. The disease is often missed because its... Read more
Consumer Wearables Could Predict Pediatric Surgery Complications
An estimated 4 million children undergo surgical procedures in U.S. hospitals each year. Postoperative complications, such as infections, can pose significant health risks to children, and timely detection... Read more
Patient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read more
Business
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
